D. Stroncek

3.1k total citations · 1 hit paper
12 papers, 2.3k citations indexed

About

D. Stroncek is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, D. Stroncek has authored 12 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 3 papers in Hematology. Recurrent topics in D. Stroncek's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). D. Stroncek is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). D. Stroncek collaborates with scholars based in United States, India and Canada. D. Stroncek's co-authors include Marianna Sabatino, Seth M. Steinberg, Crystal L. Mackall, Alan S. Wayne, Yongzhi Cui, Steven A. Feldman, Cindy Delbrook, Hua Zhang, James N. Kochenderfer and Rimas J. Orentas and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

D. Stroncek

12 papers receiving 2.3k citations

Hit Papers

T cells expressing CD19 chimeric antigen receptors for ac... 2014 2026 2018 2022 2014 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
    2014 2.2k citations Daniel W Lee, James N. Kochenderfer et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Stroncek United States 5 2.1k 665 652 580 556 12 2.3k
Nicholas Tschernia United States 7 2.1k 1.0× 614 0.9× 656 1.0× 590 1.0× 558 1.0× 20 2.3k
Rebecca Gardner United States 13 1.8k 0.9× 446 0.7× 592 0.9× 514 0.9× 504 0.9× 23 2.1k
Catherine Lindgren United States 19 2.5k 1.2× 1.1k 1.6× 801 1.2× 691 1.2× 643 1.2× 40 2.9k
Elena Mead United States 10 2.1k 1.0× 524 0.8× 597 0.9× 556 1.0× 558 1.0× 25 2.4k
Cindy Delbrook United States 16 2.9k 1.4× 792 1.2× 880 1.3× 760 1.3× 715 1.3× 27 3.3k
Antonio Di Stasi United States 16 2.2k 1.0× 954 1.4× 916 1.4× 887 1.5× 648 1.2× 42 2.8k
Barbara Camisa Italy 13 1.8k 0.8× 1.2k 1.8× 533 0.8× 598 1.0× 518 0.9× 27 2.6k
Colleen Annesley United States 19 1.5k 0.7× 305 0.5× 450 0.7× 445 0.8× 392 0.7× 52 1.8k
Sherry Adkins United States 9 1.9k 0.9× 503 0.8× 472 0.7× 451 0.8× 543 1.0× 14 2.1k

Countries citing papers authored by D. Stroncek

Since Specialization
Citations

This map shows the geographic impact of D. Stroncek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Stroncek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Stroncek more than expected).

Fields of papers citing papers by D. Stroncek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Stroncek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Stroncek. The network helps show where D. Stroncek may publish in the future.

Co-authorship network of co-authors of D. Stroncek

This figure shows the co-authorship network connecting the top 25 collaborators of D. Stroncek. A scholar is included among the top collaborators of D. Stroncek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Stroncek. D. Stroncek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Merchant, Melinda S., Donna Bernstein, Kristin Baird, et al.. (2016). Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas. Clinical Cancer Research. 22(13). 3182–3191. 87 indexed citations
3.
Purev, Enkhtsetseg, Ramaprasad Srinivasan, D. Stroncek, et al.. (2015). Outpatient allogeneic hematopoietic cell transplant following alemtuzumab based reduced intensity conditioning in patients with advanced mycosis fungoides/Sezary syndrome.. Journal of Clinical Oncology. 33(15_suppl). 7089–7089. 1 indexed citations
4.
Lee, Daniel W, James N. Kochenderfer, Maryalice Stetler‐Stevenson, et al.. (2014). T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. The Lancet. 385(9967). 517–528. 2154 indexed citations breakdown →
5.
6.
Mackall, Crystal L., Kristin Baird, Donna Bernstein, et al.. (2013). Survival in metastatic Ewing sarcoma (EWS) and rhabdomyosarcoma (RMS) following consolidation immunotherapy with autologous lymphocyte infusion, dendritic cell vaccines ± CYT107 (rhIL-7).. Journal of Clinical Oncology. 31(15_suppl). 10013–10013. 2 indexed citations
7.
Zhang, Hua, Yongzhi Cui, Nga Voong, et al.. (2011). Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells. Journal of Immunotherapy. 34(2). 187–195. 43 indexed citations
8.
Lundqvist, Andreas, Lisa Cook, Jeremy Pantin, et al.. (2009). Adoptive Infusion of Ex Vivo Expanded Autologous Natural Killer (NK) Cells in Cancer Patients Treated with Bortezomib to Sensitize to NK-TRAIL Cytotoxicity.. Blood. 114(22). 4080–4080. 2 indexed citations
9.
Confer, Dennis L., S.F. Leitman, Evangelos Papadopoulos, et al.. (2004). Serious complications following unrelated donor marrow collection: experiences of the national marrow donor program®. Biology of Blood and Marrow Transplantation. 10. 13–14. 2 indexed citations
10.
Caruccio, Lorraine, Keren Byrne, JoLynn Procter, & D. Stroncek. (2002). A novel method using formamide for the elution of antibodies from erythrocytes. Vox Sanguinis. 83(1). 63–69. 8 indexed citations
11.
McCullough, J., Celso Bianco, Arthur Bracey, et al.. (2000). Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. 35 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Tschernia Breakdown of academic impact, for papers by Rebecca Gardner Breakdown of academic impact, for papers by Catherine Lindgren Breakdown of academic impact, for papers by Elena Mead Breakdown of academic impact, for papers by Cindy Delbrook Breakdown of academic impact, for papers by Antonio Di Stasi Breakdown of academic impact, for papers by Barbara Camisa Breakdown of academic impact, for papers by Colleen Annesley Breakdown of academic impact, for papers by Sherry Adkins
Rankless by CCL
2026